Tirzepatide’s cardiovascular effects in clinical practice

• by Kathryn Wighton

• August 28, 2026

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

• by Teraya Smith

• September 2, 2026

• 5 min

Gastrointestinal Bleeding Risk Associated With Pulse Pressure in Patients With Atrial Fibrillation: Retrospective Cohort Study

• by Michel Abou Khalil, Carlo El Khoury, Yishi Jia, Maximilian Moersdorf, Christian Massad, Alex El Darzi, Yara Menassa, Mohammad Montaser Atasi, Ghassan Bidaoui, Hadi Younes, Ala Assaf, Mario Mekhael, Eli Tsakiris, Chanho Lim, Charbel Noujaim, Abboud Hassan, Yingshuo Liu, Mary Margot M Maleckar, Rodolfo A Montiel Quintero, Omar Kreidieh, Amitabh C Pandey, Han Feng, Qussay Marashly, Nassir F Marrouche

• July 20, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

• by Kathryn Wighton

• July 16, 2026

• 6 min